FORESIGHT AUTONOMOUS HOLDINGS LTD. (IL:FRSX)
TASE:FRSX
Want to see IL:FRSX full AI Analyst Report?
Top Page
Foresight
(TASE:FRSX)
Select Model
Select Model
Rating:44Neutral
Price Target:
5.00
▼(-67.53% Downside)
Action:Reiterated
Date:06/10/26
The score is driven primarily by weak financial performance—declining small revenue, sharply lower gross margin in 2025, persistent losses, and ongoing cash burn despite modest leverage. Technicals add further caution with the stock trading below major moving averages and negative MACD. Valuation provides little support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Low leverage / balance sheet flexibility
A low debt-to-equity (~0.24) reduces solvency risk and interest burden, providing durable financial flexibility. This structural conservatism lengthens runway for R&D and commercialization efforts, making it easier to absorb losses and pursue strategic partnerships without immediate refinancing pressure.
Negative Factors
Small, declining revenue base
A persistently small and declining revenue base over multiple years shows limited success scaling pilots to production. This structural revenue weakness constrains operating leverage, reduces reinvestment capacity, and undermines the company’s ability to achieve sustainable profitability without a clear path to larger contracts.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / balance sheet flexibility
A low debt-to-equity (~0.24) reduces solvency risk and interest burden, providing durable financial flexibility. This structural conservatism lengthens runway for R&D and commercialization efforts, making it easier to absorb losses and pursue strategic partnerships without immediate refinancing pressure.
Read all positive factors
Foresight (FRSX) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪19.68M
Dividend YieldN/A
Average Volume (3M)267.40K
Price to Earnings (P/E)―
Beta (1Y)0.04
Revenue GrowthN/A
EPS GrowthN/A
CountryIL
Employees81
SectorTechnology
Sector Strength88
IndustryAuto - Parts
Share Statistics
EPS (TTM)-0.17
Shares Outstanding371,385,680
10 Day Avg. Volume188,815
30 Day Avg. Volume267,397
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.77
Price to Sales (P/S)11.08
P/FCF Ratio-0.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)₪9.00M
Foresight Business Overview & Revenue Model
Company Description
Foresight Autonomous Holdings Ltd., established in 2015 and headquartered in Ness Ziona, Israel, is a technology firm dedicated to creating, developing, and commercializing advanced sensor systems. While primarily focused on the global automotive ...
How the Company Makes Money
Foresight’s primary monetization model is the commercialization of its automotive perception technology through business-to-business arrangements. Revenue is generated mainly from (1) sales of its vision/ADAS-related products and prototypes (e.g.,...
Foresight Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
52
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 460.00K | 430.82K | 436.00K | 497.00K | 550.00K | 120.00K |
| Gross Profit | 276.00K | 105.00K | 264.00K | 354.00K | 298.00K | 53.00K |
| EBITDA | -12.44M | -13.01M | -12.48M | -16.03M | -17.24M | -15.79M |
| Net Income | -12.20M | -13.10M | -11.14M | -18.41M | -21.68M | -15.04M |
Balance Sheet | ||||||
| Total Assets | 8.55M | 8.35M | 9.74M | 19.31M | 32.89M | 53.48M |
| Cash, Cash Equivalents and Short-Term Investments | 6.37M | 6.32M | 7.15M | 16.11M | 26.39M | 45.60M |
| Total Debt | 1.56M | 1.51M | 1.56M | 1.63M | 2.00M | 2.73M |
| Total Liabilities | 2.92M | 3.24M | 3.02M | 3.31M | 4.11M | 4.85M |
| Stockholders Equity | 5.93M | 6.23M | 6.07M | 15.39M | 28.33M | 48.41M |
Cash Flow | ||||||
| Free Cash Flow | -11.26M | -11.34M | -11.12M | -15.05M | -17.37M | -12.36M |
| Operating Cash Flow | -11.23M | -11.32M | -11.05M | -14.93M | -17.06M | -12.13M |
| Investing Cash Flow | -35.00K | -27.06K | 1.78M | 7.09M | 8.98M | -12.58M |
| Financing Cash Flow | 3.24M | 10.26M | 903.00K | 4.18M | 0.00 | 14.16M |
Foresight Technical Analysis
Negative
15.40
Price Trends
6.96
Negative
8.57
Negative
16.10
Negative
Market Momentum
-0.45
Positive
37.91
Neutral
3.84
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:FRSX, the sentiment is Negative. The current price of 15.4 is above the 20-day moving average (MA) of 6.18, above the 50-day MA of 6.96, and below the 200-day MA of 16.10, indicating a bearish trend. The MACD of -0.45 indicates Positive momentum. The RSI at 37.91 is Neutral, neither overbought nor oversold. The STOCH value of 3.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:FRSX.
Foresight Risk Analysis
Foresight disclosed 42 risk factors in its most recent earnings report. Foresight reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Foresight Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | ₪29.61M | -6.28 | ― | ― | 123.42% | 55.25% | |
44 Neutral | ₪19.68M | -0.17 | ― | ― | ― | ― | |
42 Neutral | ₪51.88M | -4.46 | ― | ― | 21.22% | -10.07% | |
41 Neutral | ₪202.37M | -15.84 | ― | ― | 101.06% | -8.91% |
* Technology Sector Average
IL:FRSX
Foresight
5.10
-41.10
-88.96%
IL:SCDX
Scodix
167.60
-104.32
-38.36%
IL:PHTM
Photomyne
1,764.00
-1,051.00
-37.34%
IL:NRGN
Nrgene
222.40
-17.60
-7.33%
IL:UTRN
Utron
496.70
47.40
10.55%
IL:RZR
Razor Labs
454.00
-3.70
-0.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.